comparemela.com
  1. Home
  2. Live Updates
  3. Yasushi Kajii - Breaking News

Latest Breaking News On - Yasushi kajii - Page 1 : comparemela.com

Takeda Announces Approval of ADZYNMA® Intravenous Injection 1500 (apadamtase alfa /cinaxadamtase alfa) in Japan for Patients with Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

cTTP is an Ultra-rare Blood Clotting Disorder Associated with Life-Threatening Acute Events and Debilitating Chronic Symptoms ADZYNMA is the First and Only Recombinant ADAMTS13 Enzyme.

United statesYasushi kajiiThromb haemostKremer hovingaVan dorlandEuropean medicines agencyJapan ministry of healthTakeda pharmaceutical company limitedExchange commissionDrug administrationJapanese ministry of healthTakeda pharmaceuticals united statesa incJapanese ministryOrphan drug designationProduct overviewSpecific populations

Takeda Announces Approval Of ADZYNMA Intravenous Injection 1500 In Japan

(RTTNews) - Takeda (TAK) announced the Japanese Ministry of Health, Labour and Welfare has approved the use of ADZYNMA for the treatment of congen.

Yasushi kajiiMore such health newsJapanese ministry of healthJapanese ministry

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.